Lifeward CEO Mark Grant departs, Josh Hexter named interim chief
Lifeward said Grant's exit follows a separation agreement and is unrelated to any dispute with the company, while Oramed executive Hexter steps in as interim CEO.
SEC filing
1 story
Lifeward said Grant's exit follows a separation agreement and is unrelated to any dispute with the company, while Oramed executive Hexter steps in as interim CEO.
SEC filing